Advancing the Use of Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism
Pfizer and Bristol-Myers Squibb
Pfizer and Bristol-Myers Squibb are collaborating to provide grant support for continuing professional education in the areas of anticoagulation in atrial fibrillation and venous thromboembolism. We are committed to supporting innovative, independent medical education for healthcare professionals.
The maximum individual grant ammount under this RFP will be up to $300,000 USD for initiatives with large potential, reach and impact. Smaller grant budgets will be considered.
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Application | 25-Apr-2024 4:30 pm CST | 06-May-2024 11:59pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.